Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Tuesday, December 1 2009 1:07pm ET - U.S. Markets close in 2 hours and 53 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > Calypte Biomedical Corporation Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Calypte Biomedical Corporation Company Profile
Fear of needles need not stop you from getting tested for HIV infection. Calypte Biomedical's line of HIV testing products includes several tests that use saliva rather than blood. These rapid-detection tests (sold under the Aware brand name) don't require sophisticated laboratory equipment, and Calypte hopes that such products will appeal to markets in developing countries where the incidence of HIV is high but health care infrastructure is lacking. The company has obtained regulatory approval for its Aware Rapid HIV tests in several foreign markets, including South Africa, India, and Russia. The company has also developed an Aware HIV blood test and an over-the-counter version of its oral test.
Headlines for Calypte Biomedical Corporation
CALYPTE BIOMEDICAL CORP Financials
EDGAR Online Financials - Wed Oct 14
CALYPTE BIOMEDICAL CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online - Thu Oct 8
CALYPTE BIOMEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Fri Sep 25
Calypte Biomedical Announces Changes to its Board of Directors
Business Wire - Fri Sep 25
More Headlines...
More on Calypte Biomedical Corporation
Quote Research
Profile Financials
Reports    
Contact Information
Address: 5 Centerpointe Dr., Ste. 400
Lake Oswego, OR 97035
Phone:971-204-0282
Fax:971-204-0284
Financial Highlights
Fiscal Year End:December
Revenue (2008):0.70 M
Revenue Growth (1 yr):23.10%
Employees (2008):2
Employee Growth (1 yr):(-75.00%)
Key People
Chairman: Roger I. Gale
Interim President, Interim CEO, Interim CFO, Interim Secreta: Adel Karas
VP Business Development: Christopher P. Kafka
Industry Information
Sector: Healthcare
Industry: Diagnostic Substances
Top Competitors
Inverness Medical Innovations, Inc. (ima)
OraSure Technologies, Inc. (osur)
Trinity Biotech plc (trib)
 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?